LOGIN
Diacutaneous Fibrolysis in Patients with Mild-Moderate Carpal Tunnel Syndrome
October 2022
Diacutaneous Fibrolysis in Patients with Mild-Moderate Carpal Tunnel Syndrome
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Diacutaneous Fibrolysis Intervention in Patients with Mild to Moderate Carpal Tunnel Syndrome May Avoid Severe Cases in Elderly: A Randomized Controlled Trial
Int J Environ Res Public Health. 2022 Sep 2;19(17):10983.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Forty-four patients (60 wrists) with mild-moderate carpal tunnel syndrome were randomized to receive 5 sessions of diacutaneous fibrolysis treatment (n=20, 30 wrists) or a sham treatment (n=24, 30 wrists). The primary outcome of interest was the cross-sectional area of the median nerve. Secondary outcomes of interest included numbness on a Visual Analog Scale (VAS), the thickness of the transversa...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.